Victory Net Foundation

The Neuroendocrine Carcinoma landscape is entering a new era.

A recent report from DelveInsight highlights significant market growth expected through 2036, driven by advances in:
• Targeted therapies
• Immunotherapy
• Precision oncology
• Earlier diagnosis and innovation in rare cancers

Despite remaining a rare and aggressive disease, NEC continues to attract growing attention across the healthcare and biotech industries, with promising next-generation therapies currently in development.

The future of oncology innovation is accelerating.

If interested, click here to read the full article.

💙 The power of support groups should never be underestimated. 🦓 🦋

For people living with neuroendocrine cancer, support groups provide more than just information. They offer a safe space to feel understood, connect with others who share similar experiences and gain practical advice for everyday life.

Most importantly, they remind us that no one has to face their journey alone. Through shared experiences, kindness, encouragement and hope, these communities help people navigate challenges and build resilience together.

A heartfelt thank you to all the volunteers, facilitators and members who make these groups such valuable sources of support.

📅 SAVE THE DATE 📅

On June 16, 2026, from 04pm onwards, we are delighted to welcome you to the Refuge des Bas Monts in Belmont-sur-Lausanne for our very first Summer Gathering. 🌿

On the agenda:
✨ Welcome drink and reception
🗣️ Information and discussion sessions with the participation of CHUV nurses
🤝 Opportunities for patients and caregivers to connect and share their experiences
🍹 Aperitif and dinner in a warm and friendly atmosphere

A wonderful opportunity to come together, strengthen connections, and move forward as a community.

⚠️ Don't forget to register!
📩 [email protected]

We look forward to sharing this special moment with you.

There are plenty of difficult obstacles in your path. Don’t allow yourself to become one of them.

- Ralph Marston -

📸 : NEOM

Artificial Intelligence is transforming neuroendocrine tumor care - but at what cost?

From improving diagnosis and clinical trials access to enhancing patient understanding, AI is reshaping the future of healthcare.

Yet, challenges remain: reliability, bias, data privacy and the need for transparency.
One thing is clear:
AI can support care - but human expertise must remain at the center.

🚀 The future of NEN care lies in balancing innovation with responsibility.

👉 Interested? Read the full article:
https://zurl.co/Wx0JZ

💡 Did you know?

Over 50% of neuroendocrine cancers are diagnosed at an advanced stage.
This is often because symptoms can be non-specific and sometimes misinterpreted.
Seeking medical advice when symptoms persist may help support earlier diagnosis.
Awareness plays an important role in improving patient outcomes.

👉 Learn more and help raise awareness : https://zurl.co/0o4gI.

"Courage does not always roar. Sometimes courage is the quiet voice at the end of the day saying, 'I will try again tomorrow.'"- Mary Anne Radmacher

📸: on Wirestock

Join us at the Neuroendocrine Life Alliance Patient Summit 2026 💙

📅 6 June 2026
📍 Sheffield

A day of expert insights, support, education and connection for the Neuroendocrine Community.

👉Register here: https://zurl.co/brI2z .

🤝 Putting patients at the heart of NET research

Stronger collaboration between researchers and patient advocates is key to building more meaningful, effective and patient-centered care.
From research design to clinical trials, involving patients early helps ensure that science truly meets real needs.

🌍 Together, we can:
• Improve global research collaboration
• Make clinical trials more relevant and accessible
• Turn scientific progress into real-life impact

🚀 The future of NET research is collaborative and patient-driven.

👉 Want to learn more? Read the full article: https://zurl.co/fFAEr